PTEN and female reproductive system neoplasm: Our findings demonstrate that, in this preclinical model, co-involvement of Kras and Pten tumorigenic pathways throughout the genital tract (ovaries, oviduct and uterus) consistently triggers gynecologic tumors with endometrioid histology.